See More Hear More Watch More Hear More Get on iTunes
deletedatc deletedatc

TPP Negotiators - Compromise On Biologics Drugs

A big sticking point in the negotiations over the Trans-Pacific Partnership involved biologics medicines and vaccines created from living organisms. Dispute centered on patent protection: how many years drug companies should have before facing competition from generics. Negotiators ended up with a complicated compromise that gives drug makers 5 to 8 years of protection. More Info: http://www.npr.org/2015/10/08/446980186/tpp-negotiators-reached-agreement-with-sticky-compromise-on-biologics-drugs #FullNewsAudioAvailable #NPR

UP NEXT

More from